Ee. Hatch et al., CANCER RISK IN WOMEN EXPOSED TO DIETHYLSTILBESTROL IN-UTERO, JAMA, the journal of the American Medical Association, 280(7), 1998, pp. 630-634
Context. - The association between in utero exposure to diethylstilbes
trol (DES) and clear cell adenocarcinoma (CCA) of the vagina and cervi
x is well known, yet there has been no systematic study of DES-exposed
daughters to determine whether they have an increased risk of other c
ancers, As many as 3 million women in the United States may have been
exposed to DES in utero. Objective. - To determine whether women expos
ed to DES in utero have a higher risk of cancer after an average of 16
years of follow-up. Design. - A cohort study with mailed questionnair
es and medical record review of reported cancer outcomes. Participants
. - A cohort of 4536 DES-exposed daughters (of whom 81% responded) and
1544 unexposed daughters (of whom 79% responded) who were first ident
ified in the mid-1970s. Main Outcome Measures. - Cancer incidence in D
ES-exposed daughters compared with population-based rates and compared
with cancer incidence in unexposed daughters. Results. - To date, DES
-exposed daughters have not experienced an increased risk for all canc
ers (rate ratio, 0.96; 95% confidence interval [CI], 0.58-1.56) or for
individual cancer sites, except for CCA. Three cases of vaginal CCA o
ccurred among the exposed daughters, resulting in a standardized incid
ence ratio of 40.7 (95% CI, 13.1-126.2) in comparison with population-
based incidence rates. The rate ratio for breast cancer was 1.18 (95%
CI, 0.56-2.49); adjustment for known risk factors did not alter this r
esult. Conclusions. - Thus far, DES-exposed daughters show no increase
d cancer risk, except for CCA. Nevertheless, because exposed daughters
included in our study were, on average, only 38 years old at last fol
low-up, continued surveillance is warranted to determine whether any i
ncreases in cancer risk occur during the menopausal years.